As you know, the revised Common Rule 45 CFR 46 will take effect on January 21, 2019.  Your studies will be affected in the following ways:

Those who remember the crash test dummy commercials for automobiles in the 1980s know that testing new technologies using human models first can help keep actual people safe.

When four Duke researchers developed an innovative technique for exploring the non-coding genome—the 98 percent of our DNA that does not encode protein sequences, often called the genome’s “dark ma

The first time Shree Bose saw a live beating human heart, it took her breath away.

A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rat

Kathleen Cooney, M.D., a medical oncologist and internationally known physician scientist, has been named chair of the Department of Medicine at Duke University School of Medicine.

Gene-editing Pioneer Jennifer Doudna Delivers Lefkowitz Lecture

In preparation for OnCore Go-live, the Maestro Care enrollment statuses will be updated.  The new statuses will be uploaded to the Maestro Care Production Environment (PRD) on Decem

Why do perfectly good cancer treatments suddenly stop working? Researcher and lymphoma survivor Kris Wood is finding answers. Wood’s research focuses on cancer resistance: the ability of cancer cells to activate effective biochemical defenses to protect themselves from the drugs we use to fight them.

Alumni Spotlight - Fixing the Unimaginable Pediatric and fetal surgeon Holly Hedrick, MD’91, gives hope for families and babies with complex birth defects